SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?


To: keithcray who wrote (5206)7/12/2001 7:39:12 AM
From: keithcray  Respond to of 208838
 
DNA Downgraded by ABN AMRO

07:33 ET Genentech (DNA) 42.75: ABN AMRO downgrades to ADD from Buy following what firm views as disappointing sales of Rituxan for the latest qtr. Expects near-term weakness in the stock as Rituxan sales may not meet some expectations that are in the marketplace.



To: keithcray who wrote (5206)7/12/2001 7:40:27 AM
From: Mr. Big  Read Replies (1) | Respond to of 208838
 
What's the plan man. You think this thing has legs or we bop early?



To: keithcray who wrote (5206)7/12/2001 7:44:40 AM
From: Jeff Jordan  Respond to of 208838
 
hmmm, well I have my futures trading platform connected, Cybertrader and Qcharts!....scary

NQ 20pts off highs.....

I may be able to limp along if I don't loose connection<g>

I am so spoiled!